Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02059889

Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Virginia Commonwealth University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

This clinical trial studies diffusion-weighted magnetic resonance imaging (MRI) in identifying and localizing tumors in patients with non-small cell lung cancer undergoing radiation therapy. Diagnostic procedures such as diffusion weighted MRI may help identify where active cancer is to improve the targeting accuracy of radiotherapy. Comparing results of diagnostic procedures done before, during, and after radiation therapy may help determine how the location and volume of tumors changes over time and predict how the tumor will respond to therapy.

Detailed description

PRIMARY OBJECTIVES: I. Assess diffusion-weighted MRI as an early predictor for tumor response in patients with non-small cell lung cancer (NSCLC). II. Establish the potential of individualized radiotherapy targeting of radioresistant tumor sub-volumes. OUTLINE: Patients undergo diffusion-weighted MRI within 4 weeks of radiation start (baseline), during the second week of radiation therapy, during the fourth week of radiation therapy, and at 3 months after radiation therapy (post-treatment). Patients also undergo standard of care 4-dimensional (4D) computed tomography (CT) and fludeoxyglucose F 18 (FDG)-positron emission tomography (PET) at the same time points.

Conditions

Interventions

TypeNameDescription
DEVICEdiffusion-weighted magnetic resonance imagingUndergo diffusion-weighted MRI
DEVICE4-dimensional computed tomographyUndergo 4D CT
RADIATIONfludeoxyglucose F 18Undergo FDG-PET
DEVICEFDG-PETUndergo FDG-PET

Timeline

Start date
2014-07-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2014-02-11
Last updated
2016-12-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02059889. Inclusion in this directory is not an endorsement.